ciprofloxacin has been researched along with Impetigo in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Impetigo: A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin in a low dosage of 250 mg twice a day was applied in the treatment of bacterial infections of the skin." | 3.67 | [The effectiveness of ciprofloxacin in bacterial skin infections]. ( Blenk, H; Meisel, C, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meisel, C | 1 |
| Blenk, H | 1 |
1 other study available for ciprofloxacin and Impetigo
| Article | Year |
|---|---|
[The effectiveness of ciprofloxacin in bacterial skin infections].
Topics: Administration, Oral; Bacterial Infections; Ciprofloxacin; Drug Administration Schedule; Erysipelas; | 1988 |